Email this article to a friend
Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response
-
* Corresponding author: Dimitrios T Boumpas boumpasd@med.uoc.gr
- † Equal contributors
Arthritis Research & Therapy 2009, 11:R131 doi:10.1186/ar2798